Ji-wei Liu
Clinical Key Laboratory Of Integrative Medicine
Dalian, 116000, China
Dalian, 116000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Disproportionality analysis of adverse events associated with tyrosine kinase inhibitors in gastrointestinal stromal tumors in the FDA adverse event reporting system.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 11, 2026
E3 ligase TRIM22 promotes melanoma proliferation by regulating cell cycle progression through K63-linked ubiquitination of p21.
Journal: Scientific reports
Published: March 01, 2025
From awareness to action: Revolutionizing cardio-oncology in China.
Journal: Seminars in cancer biology
Published: October 30, 2024
Peripheral inflammatory factors as prognostic predictors for first-line PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer.
Journal: Scientific reports
Published: June 03, 2024
Correction to: An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases.
Journal: Oncogene
Published: November 18, 2022
Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway.
Journal: Frontiers in pharmacology
Published: March 28, 2022
Association between cigarette smoking and colorectal cancer sidedness: A multi-center big-data platform-based analysis.
Journal: Journal of translational medicine
Published: January 06, 2021
Emergence, Development, and Future of Cardio-Oncology in China.
Journal: Chinese medical journal
Published: November 02, 2018
Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.
Journal: Chinese clinical oncology
Published: November 22, 2016
Last Updated: 09/26/2026